alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Sharpe Resources Corporation 

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

I, Roland M. Larsen, Chief Executive Officer of Sharpe Resources Corporation (“the Company”), certify that: 
- 1. the annual report on Form 20F of the Company for the fiscal year ending December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and  2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

/s/ Roland M. Larsen 
Roland M. Larsen 
Chief Executive Officer 
July 20, 2004 

**Sharpe Resources Corporation 

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

I, Kimberly L. Koerner, Director of Sharpe Resources Corporation (“the Company”), certify that: 
- 1. the annual report on Form 20F of the Company for the fiscal year ending December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and  2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

/s/ Kimberly L. Koerner 
Kimberly L. Koerner 
Director 
July 20, 2004 

**Sharpe Resources Corporation 

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

I, Troy Koerner, Director of Sharpe Resources Corporation (“the Company”), certify that: 
- 3. the annual report on Form 20F of the Company for the fiscal year ending December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and  4. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

/s/ Troy Koerner 
Troy Koerner 
Director 
July 20, 2004************
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications,  the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Institute of Child Health and Human Development Initial Review Group; Reproduction, Andrology, and Gynecology Subcommittee.                    

*Date:*                         March 10, 2008.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Dennis Leszczynski, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892, (301) 435-2717,                         *leszczyd@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.939, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: February 6, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy. 

[FR Doc. 08-633  Filed 2-12-08; 8:45 am]

BILLING CODE 4140-01-M
I 

115TH CONGRESS 

2D SESSION H. R. 5872 

To amend the Internal Revenue Code of 1986 to increase the limitation 

on the deduction for State and local taxes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 17, 2018 

Mr. ROHRABACHER introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to increase 

the limitation on the deduction for State and local taxes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. INCREASE IN LIMITATION ON DEDUCTION FOR 

4 STATE AND LOCAL TAXES. 

5 (a) IN GENERAL.—Section 164(b)(6)(B) of the Inter6 nal Revenue Code of 1986 is amended by striking 

7 ‘‘$10,000 ($5,000’’ and inserting ‘‘$20,000 ($10,000’’. 


pbinns on DSK79D2C42PROD with BILLS
2 

•HR 5872 IH

1 (b) EFFECTIVE DATE.—The amendment made by 

2 this section shall take effect as if included in the amend3 ments made by section 11042 of Public Law 115–97. 

Æ 


pbinns on DSK79D2C42PROD with BILLS
ex10-2.htm


EXHIBIT 10.2


 


Director Fee Arrangements for Fiscal 2014


 


Each director of Southern Missouri Bancorp, Inc. (the "Company") also is a director of Southern Bank (the "Bank"). For Fiscal 2014, each director receives a monthly fee of $900 for serving on the Company's Board of Directors and $1,100 for serving on the Bank's Board of Directors.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Transportation

###### Federal Aviation Administration

          - 14 CFR Part 71
          - [Docket No. FAA-2005-22490; Airspace Docket No. 05-AEA-018]

# AGENCY:

Federal Aviation Administration (FAA), DOT.

# ACTION:

Direct final rule; confirmation of effective date.

# SUMMARY:

This action confirms the effective date of a direct final rule that amends a Class E airspace area to support Area Navigation (RNAV) Global Positioning System (GPS) Special Instrument Approach Procedures (IAPs) that serve the Pottsville Hospital (91PN), Pottsville, PA.

# DATES:

Effective 0901 UTC, December 20, 2007. The Director of the Federal Register approves this incorporation by reference action under Title 1, Code of Federal Regulations, part 51, subject to the annual revision of FAA Order 7400.9 and publication of conforming amendments.

# FOR FURTHER INFORMATION CONTACT:

Daryl Daniels, Airspace Specialist, System Support, AJO2-E2B.12, FAA Eastern Service Center, 1701 Columbia Ave., College Park, GA 30337; telephone (404) 305-5581; fax (404) 305-5572.

# SUPPLEMENTARY INFORMATION:

## Confirmation of Effective Date

                    The FAA published this direct final rule with a request for comments in the                     **Federal Register**                     on November 2, 2007 (72 FR 62108-62110). The FAA uses the direct final rulemaking procedure for a non-controversial rule where the FAA believes that there will be no adverse public comment. This direct final rule advised the public that no adverse comments were anticipated, and that unless a written adverse comment, or a written notice of intent to submit such an adverse comment, were received within the comment period, the regulation would become effective on December 20, 2007. No adverse comments were received, and thus this notice confirms that effective date.                

Issued in College Park, GA, on December 17, 2007. 

Mark D. Ward,

Manager, System Support Group, Eastern Service Center.

[FR Doc. 08-204 Filed 1-23-08; 8:45 am]

BILLING CODE 4910-13-M
AGENDA

Advisory Board on Radiation and Worker Health – Meeting 145

Videoconference:

Join ZoomGov Meeting

https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09

Meeting ID: 160 6763 3819

Passcode: ABRWH#01

Teleconference:

Phone: +1 646 828 7666 (U.S. East)

Phone: +1 669 254 5252 (U.S. West)

Meeting ID: 160 6763 3819

Passcode: 98685439

Wednesday, April 27, 2022

NOTE: All times in Eastern Time

1:00 p.m. – 1:15 p.m. Welcome Dr. Henry Anderson, Chair

1:15 p.m. – 1:30 p.m. NIOSH Program Update Mr. Grady Calhoun, NIOSH 

1:30 p.m. – 1:45 p.m. DOL Program Update Mr. Frank (Chris) Crawford, 

DOL 

1:45 p.m. – 2:00 p.m. DOE Program Update Mr. Greg Lewis, DOE

2:00 p.m. – 3:30 p.m. Procedures Review 

Finalization/Document 

Approvals

Ms. Josie Beach, Chair, 

Subcommittee on Procedures 

Review

Ms. Kathleen Behling, SC&A

3:30 p.m. – 4:00 p.m. Break

4:00 p.m. – 5:00 p.m. Update on review of SEC00253 Reduction Pilot Plant, 

Huntington, WV: Jun. 7, 

1976–Nov. 26, 1978

Dr. Henry Anderson, Chair, 

Uranium Refining Atomic 

Weapons Employer 

(URAWE)

5:00 p.m. – 6:00 p.m.* Public Comment

* Public comment period will conclude at 6:00 p.m. or following the final call for public comment, 

whichever comes first. If you plan to comment, please be prepared to comment at 5:00 p.m.
Thursday, April 28, 2022

NOTE: All times in Eastern Time

1:00 p.m. – 1:15 p.m. Welcome Dr. Henry Anderson, Chair

1:15 p.m. – 1:30 p.m. SEC Petitions Status Update Mr. Chuck Nelson, NIOSH

1:30 p.m. – 2:30 p.m. Update on review of SEC00188 Sandia Petition 

Addendum 2; Jan. 1, 1997 – 

May 21, 2011

Dr. Henry Anderson, Chair

Sandia Workgroup 

Mr. Joe Fitzgerald, SC&A 

Petitioner:

2:30 p.m. – 2:50 p.m. Subcommittee on Dose 

Reconstruction Reviews 

Update & Discussion

Dr. David Kotelchuck, Chair,

Subcommittee on Dose 

Reconstruction Reviews

2:50 p.m. – 3:00 p.m. Break

3:00 p.m. – 4:00 p.m. Board Work Session Dr. Henry Anderson, Chair
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commodity Futures Trading Commission

# Agency Holding The Meeting:

Commodity Futures Trading Commission.

# Time And Date:

2 p.m., Wednesday March 19, 2008.

# Place: 

1155 21st St., NW., Washington, DC, 9th Floor Commission Conference Room.

# Status:

Closed.

# Matters To Be Considered:

Enforcement Matters.

# FOR FURTHER INFORMATION CONTACT:

Sauntia S. Warfield, 202-418-5084.

David A. Stawick,

Secretary of the Commission.

[FR Doc. 08-846 Filed 2-21-08; 11:53am]

BILLING CODE 6351-01-M
ORNL Site Profile Comments Page 1 of 2

Miller, Diane M.

From: —Barncord, J. David_ -
Sent: | Tuesday, November 16, 2004 10:14 AM
To: NIOSH Docket Office

Ce: Barncord, J. David

Subject: ORNL Site Profile Comments

I would like to make a comment on the site profile at ORNL. In the profile, there is a
very small amount of information about buildings 4500 South and 4500 North. These
buildings have in the past and are presently used in bench top type research. Granted,
they would pose little exposure to the researcher doing the small scale work but they
would however, pose a risk to the maintenance worker. The maintenance staff was and is
responsible for all utilities in these buildings which includes the hot and process drains.
When these drains did not work properly they were repaired by the maintenance
workers. This maintenance also included the building ventilation system. The HEPA
filtered chemical hoods and the RAD ventilation systems were a major source of
exposure to the maintenance worker.

I would also like to explain how people were assigned to work areas. It may show up on
someone's work history that they were assigned to a certain building but that can be very
misleading. I myself worked in a building that when looked up on the site profile, would
appear as a clean building. However all the maintenance that was performed on the ORNL
site radiological waste lines were done by personnel from this maintenance shop. Please
understand that we had central maintenance shops that were responsible for maintenance
all over ORNL. It would not be correct to assume that because a worker was not assigned
to a certain building that he or she did not actually do work in that particular building.
The issue of overtime must also be considered. Workers from all over the plant site are
asked to work overtime on any particular job. A worker that would normally work ina
clean area could in fact receive an exposure on an overtime job. I understand this would
be very difficult to capture in the site profile but I feel it should be a consideration
when calculating a workers potential for exposure.

Finally, I would like to comment on the type of work done at ORNL. Being a research
facility, we did not have what would be called a production type atmosphere. The types
of projects in the different buildings changed with the availability of funding. The
research projects being done in a certain part of a building with whatever hazardous
material that was being used could change many many times during the career of a
maintenance worker. Chemicals changed, radioisotopes changed but the maintenance
workers remained the same.

11/16/2004


ORNL Site Profile Comments Page 2 of 2

Thank you for the opportunity to comment,

Dave Barncord

Dave Barncord

ATLC ES&H Representative

11/16/2004
Ameritas
Life
Insurance
Corp.


 


FOUR-YEAR
SURRENDER CHARGE
RIDER


 


This
rider
is made
a part
of the
policy
and is
based
on the
application
and payment
of the
premium.
 This
rider
is subject
to the
terms
and provisions
of the
policy
and this
rider.
 If
there
is a
conflict
between
the
terms
of the
policy
and the
terms
of this
rider,
the
rider language
controls.
 This
rider
may
not be
cancelled
and will
terminate
when
the
policy
to which
it is
attached
terminates
or the
maturity
date.


 


BENEFITS.
 By
attachment
of this
rider
to the
policy,
the
following
surrender
charge
schedule
replaces
the surrender
charge
schedule
noted
on your
policy
schedule.


 


	Completed Years Since Receipt of Premium	Surrender Charge Percentage
	0	8%
	1	8%
	2	8%
	3	7%
	4 and thereafter	0%


 


RIDER
CHARGE.
 Beginning
with
the
policy
date,
each
month
until
the
rider
terminates,
we will
deduct
a rider
charge
pro-rata
from
your
fixed
account
and subaccounts.
 The
current
and maximum
charges
are
stated
on your
rider
schedule.
 When
your
rider
is issued,
the
current
charge
applies.
 After
the
first
policy
year,
we reserve
the right
to change
the
current
charge
at any
time;
however,
your
charge
will
never
exceed
the maximum
charge.
  If the rider charge rate increases, we will notify you at least 30 days prior to the policy anniversary.


 


 


AMERITAS
LIFE
INSURANCE
CORP.


 


 


	[	SPECIMEN	SPECIMEN	]
	   President	Secretary   


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


ICC15
4YSCR 8-15
EXHIBIT 31.2

Chief Financial Officer Certification

I, Wendy A. Nieto, certify that:

(1)  I have reviewed this annual report on Form 10-K of Intraware, Inc. (the "registrant");

(2)  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;

(3)  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)  The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(i)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;

(ii)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(iii)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and

(5)  The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(i)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(ii)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.

Dated:    April 25, 2007

|/s/  WENDY A. NIETO
                Wendy A. NietoExecutive Vice President and Chief Financial Officer of
   Intraware, Inc.
   (Principal Financial Officer) | 
|------------------------------------------------------------------------------------------------------------------------------------------------------------- | 

---
EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8
(Nos. 333-53902, 333-93823 and 333-74209) and on Form S-3 (Nos. 333-109969, 333-107881, 333-90442, 333-89566, 333-65112
and 333-53858) of Intraware, Inc. of our report dated April 18, 2006 relating to the financial statements which appears in this
Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California
   April 18, 2006

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel; SWAN.                     

*Date:*                         March 4, 2008.                    

*Time:*                         2 p.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute on Aging, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20814 (Telephone Conference Call).                    

*Contact Person:*                         Alicja L. Markowska, PhD, DSC, National Institute on Aging, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-496-9666,                         *markowsa@nia.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: February 13, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-774 Filed 2-20-08: 8:45 am]

BILLING CODE 4140-01-M